Genomic Characterisation of Carbapenem Non-susceptible Pseudomonas aeruginosa in SingaporePseudomonas aeruginosa is a clinically important pathogen implicated in many hospitalacquired infections. Its propensity to acquire broad-spectrum resistance has earned the organism its status as a severe public health threat requiring urgent control measures.While whole genome sequencing-based genomic surveillance provides a mean to track antimicrobial resistance, its use in molecular epidemiological surveys of Pseudomonas aeruginosa remains limited, especially in the Southeast Asian region. We sequenced the whole genomes of 222 carbapenem non-susceptible P. aeruginosa (CNPA) isolates collected in 2006-2020 at the largest public acute care hospital in Singapore . Antimicrobial susceptibilities were determined using broth microdilution. Clonal relatedness, multi-locus sequence types and antimicrobial resistance determina nts (acquired and chromosomal) were determined. In this study, CNPA exhibited broadspectrum resistance (87.8% multi-drug resistance), retaining susceptibility only to polymyxin B (95.0%) and amikacin (55.0%). Carbapenemases were detected in 51.4% of the isolates, where IMP and NDM metallo-β-lactamases were the most frequent.Carbapenem resistance was also likely associated with OprD alterations or efflux mechanisms (ArmZ/NalD mutations), which occurred in strains with or without carbapenemases. The population of CNPA in the hospital was diverse; the 222 isolates grouped into 68 sequence types (ST), which includes various high-risk clones. We detected an emerging clone, the NDM-1-producing ST308, in addition to the global highrisk ST235 clone which was the predominant clone in our population. Our results thus provide a "snapshot" of the circulating lineages of CNPA locally and the prevailing 4 genetic mechanisms contributing to carbapenem resistance. This database also serves as the baseline for future prospective surveillance studies.